List of admitted cannabis intermediate products

Updated 09 March 2022

Any cannabis intermediate product and related cannabis primary product that are to be comprised by the medicinal cannabis pilot programme must be admitted to a list published by the Danish Medicines Agency. The list allows anyone to see which cannabis intermediate products are comprised by the pilot programme, and hence which products may be lawfully prescribed by doctors and lawfully dispensed by pharmacies in Denmark. Information about how to apply for admission of cannabis intermediate products is available here: Admission to the Danish Medicines Agency's list.

The Danish Medicines Agency’s list of admitted cannabis intermediate products and cannabis primary products provides the name, strength, product form and pack size of each specific product. Admitted cannabis intermediate products will appear on the list on the first business day after inclusion.

List of admitted cannabis intermediate products and cannabis primary products (Excel)

If a cannabis intermediate product and its related cannabis primary product are admitted to the Danish Medicines Agency's list, it does not necessarily mean it is available for prescription by a doctor. After admission to the list, it may take some time before the manufacturer is ready to make it available for prescription and dispensing. But there are also other factors which could make a cannabis intermediate product unavailable for a period of time, for instance if the manufacturer is experiencing supply problems. At Medicinpriser.dk (Medicine Prices), you can see which cannabis products are available for prescription and subsequent dispensing at a pharmacy. Click the link below to see a list of currently available cannabis products.

Link to Medicinpriser.dk (Medicine Prices) (on medicinpriser.dk: click on one of the products under the heading "Cannabis product" to see the price)

Product sheets of admitted cannabis intermediate products

The table below provides the product name, strength and product form and links to the product sheet of each cannabis intermediate product. Cannabis products should always be used according to a doctor’s instructions. If doubts arise, seek advice from a doctor.

Each product sheet has been completed by the intermediate product manufacturer of the cannabis intermediate product. It contains information consistent with the information declared on the packaging of the cannabis intermediate product.

Patient information sheets of admitted cannabis intermediate products

If a cannabis intermediate product is supplied with a patient information sheet (description of the preparation method), a link to this document is also provided in the list below.

Name

Dronabinol (THC) strength

Cannabidiol (CBD) strength

Product form

Link to product sheet and preparation method, if any

Bedica "CannGros"  140 mg/g  Under 10 mg/g  Herbal tea / inhalation vapor

Product sheet, Bedica "Canngros"

Preparation method, Bedica "CannGros"

Bediol "CannGros"

63 mg/g

80 mg/g

Herbal tea / inhalation vapor

Product sheet, Bediol "CannGros"

Preparation method, Bediol "CannGros"

Bediol "Scanleaf" 63 mg/g  80 mg/g   Herbal tea/inhalation vapour, herbal substance

Product sheet, Bediol "Scanleaf"

Preparation method, Bediol "Scanleaf"

Bedrocan "CannGros"

220 mg/g

Under 10 mg/g

Herbal tea / inhalation vapor

Product sheet, Bedrocan "CannGros"

Preparation method, Bedrocan "CannGros"
Billinol "LGP" 160 mg/g Maximum 2 mg/g Inhalation vapour, herbal substance

Product sheet, Billinol "LGP"

Preparation method, Billinol "LGP"

THC Olie "Stenocare" 30 mg/ml 
Under 0.1 mg/ml 
Oromucosal solution 

Product sheet, THC Olie "Stenocare"

Patient information sheet, THC Olie "Stenocare"

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.


...